ARG1 and hepatocellular carcinoma: These MDSCs can suppress the tumor-killing activity of CIKs in HCC in an Arg-1/iNOS-dependent manner, which is reversed by treatment with the phosphodiesterase 5 (PDE5) inhibitor tadalafil [62].